Oladipupo Olafiranye, MD, MS, FACC, FSCAI

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Novo Nordisk
    Topic:
    ARTEMIS TRIAL
    Date added:
    10/14/2025
    Date updated:
    10/14/2025
    Relationship end date:
    01/31/2027
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Recor Medical
    Topic:
    US GPS
    Date added:
    10/14/2025
    Date updated:
    10/14/2025
    Relationship end date:
    07/31/2031
Return to 102 Cardiology Clinical Conference (FY26) "Mending Busted Genes: Hereditary Arrhythmogenic Cardiomyopathy" & "The Evolving Landscape of Multivessel CAD Revascularization: PCI vs CABG Saga" (101525)

 

**Disclaimer**

This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.